Amgen Inc.AMGNNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +23.18% | +10.86% | +9.43% | +9.29% | +12.40% |
| Gross Profit Growth | +1.88% | +17.51% | +21.99% | +19.49% | +24.69% |
| EBITDA Growth | +46.43% | -4.16% | +89.47% | +20.49% | +12.14% |
| Operating Income Growth | +1.29% | +81.83% | +18.87% | +38.50% | +23.40% |
| Net Income Growth | +63.58% | -18.25% | +0.00% | +91.96% | +13.64% |
| EPS Growth | +63.16% | -18.18% | +0.00% | +91.37% | +13.47% |
| EPS Diluted Growth | +62.11% | -18.31% | +0.00% | +92.03% | +13.60% |
| Weighted Average Shares Growth | +0.37% | +1.03% | +0.37% | +0.19% | +0.19% |
| Weighted Average Shares Diluted Growth | +0.74% | +0.37% | +0.93% | +0.00% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +29.38% | +786.80% | +101.89% | -7.28% | +31.17% |
| Free Cash Flow Growth | +31.93% | +1422.49% | +113.51% | -13.96% | +28.18% |
| Receivables Growth | +19.07% | -5.55% | +20.01% | +25.48% | +16.03% |
| Inventory Growth | +46.48% | -26.48% | -22.87% | -17.66% | -13.80% |
| Asset Growth | +0.39% | -5.47% | -3.89% | -3.31% | -0.82% |
| Book Value per Share Growth | -2.05% | -6.66% | +23.14% | +25.13% | +27.56% |
| Debt Growth | -0.12% | -6.99% | -10.37% | -10.28% | -9.62% |
| R&D Expense Growth | +34.38% | +12.39% | +10.65% | +20.53% | +31.03% |
| SG&A Expenses Growth | +20.10% | -17.41% | -6.69% | -5.27% | +5.85% |